A detailed history of Geode Capital Management, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 286,644 shares of STIM stock, worth $515,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares
286,644
Previous 265,604 7.92%
Holding current value
$515,959
Previous $770,000 77.14%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.68 - $4.8 $56,387 - $100,992
21,040 Added 7.92%
286,644 $1.36 Million
Q4 2023

Feb 13, 2024

BUY
$1.05 - $2.9 $16,658 - $46,008
15,865 Added 6.35%
265,604 $770,000
Q3 2023

Nov 13, 2023

BUY
$1.29 - $2.22 $259 - $446
201 Added 0.08%
249,739 $337,000
Q2 2023

Aug 11, 2023

SELL
$2.07 - $2.92 $12,989 - $18,323
-6,275 Reduced 2.45%
249,538 $536,000
Q1 2023

May 15, 2023

BUY
$2.81 - $6.71 $73,633 - $175,828
26,204 Added 11.41%
255,813 $744,000
Q4 2022

Feb 13, 2023

BUY
$3.44 - $6.87 $33,457 - $66,817
9,726 Added 4.42%
229,609 $1.58 Million
Q3 2022

Nov 14, 2022

BUY
$2.35 - $4.66 $7,153 - $14,185
3,044 Added 1.4%
219,883 $699,000
Q2 2022

Aug 12, 2022

SELL
$2.09 - $3.71 $368,732 - $654,544
-176,427 Reduced 44.86%
216,839 $696,000
Q1 2022

May 13, 2022

SELL
$2.84 - $4.52 $8,491 - $13,514
-2,990 Reduced 0.75%
393,266 $1.19 Million
Q4 2021

Feb 11, 2022

BUY
$3.87 - $6.59 $365,184 - $621,852
94,363 Added 31.26%
396,256 $1.77 Million
Q3 2021

Nov 12, 2021

SELL
$6.22 - $15.54 $470,897 - $1.18 Million
-75,707 Reduced 20.05%
301,893 $1.98 Million
Q2 2021

Aug 13, 2021

BUY
$10.15 - $17.25 $2.16 Million - $3.66 Million
212,430 Added 128.61%
377,600 $6.05 Million
Q1 2021

May 12, 2021

BUY
$10.6 - $21.27 $710,528 - $1.43 Million
67,031 Added 68.3%
165,170 $2.04 Million
Q4 2020

Feb 12, 2021

BUY
$4.95 - $11.45 $103,544 - $239,511
20,918 Added 27.09%
98,139 $1.09 Million
Q3 2020

Nov 13, 2020

SELL
$1.82 - $5.87 $438 - $1,414
-241 Reduced 0.31%
77,221 $375,000
Q2 2020

Aug 13, 2020

SELL
$1.41 - $2.61 $117,582 - $217,653
-83,392 Reduced 51.84%
77,462 $149,000
Q1 2020

May 14, 2020

BUY
$1.28 - $4.5 $20,568 - $72,310
16,069 Added 11.1%
160,854 $304,000
Q4 2019

Feb 13, 2020

BUY
$4.03 - $9.22 $68,892 - $157,615
17,095 Added 13.39%
144,785 $650,000
Q3 2019

Nov 12, 2019

BUY
$8.31 - $13.03 $2,584 - $4,052
311 Added 0.24%
127,690 $1.06 Million
Q2 2019

Aug 14, 2019

BUY
$9.0 - $17.2 $171,495 - $327,746
19,055 Added 17.59%
127,379 $1.59 Million
Q1 2019

May 14, 2019

BUY
$13.6 - $19.58 $472,654 - $680,483
34,754 Added 47.24%
108,324 $1.65 Million
Q4 2018

Feb 13, 2019

BUY
$16.0 - $31.84 $208,528 - $414,970
13,033 Added 21.53%
73,570 $1.42 Million
Q3 2018

Nov 13, 2018

BUY
$24.32 - $37.54 $1.47 Million - $2.27 Million
60,537 New
60,537 $1.94 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $48.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.